BMO Capital Reiterates Outperform Rating on Bath & Body Works Inc. (BBWI)

BMO Capital analyst Simeon Siegel reiterated an Outperform rating and $50.00 price target on Bath & Body Works Inc. (NYSE: BBWI).

The analyst commented, "A better top-line (offsetting investor concerns) and SGA offset slightly-lower GM (planned promos) to drive an EPS beat. Management raised 4Q guidance (historically represents >40% of FY sales/>50% of EBIT/EPS), for the first above-Street guide in 5 quarters. We believe BBWI has see-sawed from investor-loved to feared and although we recognize a lighter GM/EBIT means it's not out-of-the-woods, better Revenue/EPS, positive comments around “normalization” should offer a breathe-out moment as management works to execute Holiday for what we continue to believe remains an under-earning and undervalued business. Reiterate Outperform."

For an analyst ratings summary and ratings history on Bath & Body Works Inc. click here. For more ratings news on Bath & Body Works Inc. click here.

Shares of Bath & Body Works Inc. closed at $35.78 yesterday.

You May Also Be Interested In

• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
• Home Depot (HD) PT Raised to $354 at Bernstein SocGen Group
• UiPath launches Maestro Flow for coding agent orchestration